Hereditary Neoplastic Syndrome clinical trials
15 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening
- Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer Syndromes
- Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
- Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
- Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening
- Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
- Identifying and Caring for Individuals With Inherited Cancer Syndrome
- Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
- Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
- Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
- Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
- A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families
- Applying Population Management Best Practices to Preventative Genomic Medicine Trial
- Strategy for Management of Patients With Hereditary Cancer Syndromes (HCS) in a Rural Environment
- Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Hereditary Neoplastic Syndrome” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.